Michigan Dupixent Lawsuit Lawyers

A defective drug attorney can help if you developed cancer after using Dupixent (dupilumab). Dupixent is a prescription biologic medication used to treat eczema, asthma, and other inflammatory conditions. While it has helped many patients, growing evidence and lawsuits suggest the drug may be linked to a rare form of cancer known as Cutaneous T-Cell Lymphoma (CTCL).

Patients across the United States are now filing lawsuits alleging that the manufacturers failed to warn doctors and patients about this potential risk.

• What Injuries Are Linked to Dupixent?
• What Is Cutaneous T-Cell Lymphoma (CTCL)?
• Do I Qualify to File a Dupixent Lawsuit?
• Contact a Dupixent Lawsuit Attorney for a Free Case Evaluation

What is Dupixent Lawsuit Used For?

Dupixent is a monoclonal antibody that works by blocking certain immune system pathways that cause inflammation. It was approved to treat moderate-to-severe eczema and has since been expanded to other conditions.

However, recent studies and adverse event reports have raised concerns that Dupixent may:

• Increase the risk of developing CTCL
• Worsen or accelerate existing, undiagnosed lymphoma
• Delay diagnosis by masking cancer symptoms

Lawsuits allege that manufacturers failed to adequately warn about the connection between Dupixent and T-cell lymphoma, including CTCL.

Some research suggests patients taking Dupixent (dupilumab) may face a significantly higher risk of developing CTCL compared to those not taking the drug.

What Injuries Are Linked to Dupixent?

The primary injury linked to Dupixent lawsuits is the development or progression of CTCL and other T-cell lymphomas.

Reported complications include:

• New diagnosis of CTCL after starting Dupixent
• Worsening or accelerated progression of lymphoma
• Delayed cancer diagnosis due to symptom overlap
• Spread of cancer to lymph nodes or organs
• Death in severe cases

Some reports suggest Dupixent may mask early cancer symptoms, allowing the disease to progress undetected.

What Is Cutaneous T-Cell Lymphoma (CTCL)?

Cutaneous T-Cell Lymphoma (CTCL) is a rare type of non-Hodgkin lymphoma that begins in white blood cells (T-cells) and primarily affects the skin.

In the early stages, CTCL can appear similar to eczema or dermatitis, making it difficult to diagnose. Over time, it can progress into a more serious disease affecting lymph nodes, blood, and internal organs.

Common forms of CTCL include:

• Mycosis fungoides
• Sezary syndrome

Because Dupixent is used to treat skin conditions like eczema, some patients may unknowingly have early-stage CTCL that is misdiagnosed and worsened during treatment.

What Are the Symptoms of CTCL?

CTCL symptoms often resemble common skin conditions, especially in early stages.

Warning signs may include:

• Red, scaly patches or rashes
• Persistent itching
• Thickened plaques or skin lesions
• Skin discoloration
• Swollen lymph nodes
• Fatigue or unexplained weight loss

Because these symptoms mimic eczema, CTCL is often misdiagnosed or diagnosed late.

Who Is at Risk?

Patients who took Dupixent for inflammatory conditions may be at risk, especially if symptoms did not improve or worsened over time.

Dupixent is commonly prescribed for:

• Eczema (atopic dermatitis)
• Asthma
• Chronic sinusitis with nasal polyps
• Other inflammatory skin conditions

Many lawsuits involve patients who were treated for eczema but later diagnosed with CTCL.

What Should Patients Do?

If you used Dupixent and are experiencing unusual or worsening skin symptoms, you should:

• Seek immediate medical evaluation
• Ask about testing for CTCL or other lymphomas
• Request copies of your medical records
• Avoid delaying diagnosis if symptoms persist

Early detection is critical for improving outcomes in CTCL cases.

Do I Qualify to File a Dupixent Lawsuit?

You may qualify to file a lawsuit if:

• You used Dupixent for eczema, asthma, or another condition
• You were later diagnosed with CTCL or another T-cell lymphoma
• Your condition worsened or was misdiagnosed during treatment

Even if you are unsure whether Dupixent contributed to your diagnosis, a legal review can help determine your eligibility.

Compensation Available in a Dupixent Lawsuit

Individuals diagnosed with CTCL after using Dupixent may be eligible to recover compensation for:

• Medical expenses, including cancer treatment
• Lost wages or reduced earning capacity
• Pain and suffering
• Long-term disability or reduced quality of life
• Wrongful death damages (for families)

Settlement amounts depend on the severity of the illness and its long-term impact.

Contact a Dupixent Lawsuit Attorney for a Free Case Evaluation

If you or a loved one developed cutaneous T-cell lymphoma after using Dupixent, Buckfire Law can help. We provide a free, no-obligation case review. If you qualify for a claim, we will file your lawsuit with no upfront legal fees or costs, and we will only receive a fee if you win a settlement! 

Legally reviewed by:

Lawrence J. Buckfire, J.D., Lead Trial Attorney at Buckfire Law
Lawrence J. Buckfire, J.D. has over 30 years of experience specializing in personal injury and wrongful death cases. He earned his undergraduate degree from the University of Michigan and attended Wayne State University School of Law. Lawrence has been named a Super Lawyer, U.S. News Best Lawyer, and in The National Trial Lawyers-Top 100 Trial Lawyers.
Date of Review: May, 2026